C. V. D. Velde

C. V. D. van de Velde, C. Markopoulos, R. Masetti, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

H. Putter, P. Kuppen, S. Noguchi, 2009, British Journal of Cancer.

Influence of hospital type on outcomes after oesophageal and gastric cancer surgery

H. Putter, C. V. D. van de Velde, V. Lemmens, 2012, The British journal of surgery.

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

I H Kunkler, C. Seynaeve, G. Kerr, 2014, British Journal of Cancer.

Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer

Sylvain Gioux, Alan Stockdale, Hein Putter, 2011, Annals of Surgical Oncology.

Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?

H. Putter, M. Aapro, J. Bartlett, 2013, Breast.

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.

C. V. D. van de Velde, S. Verma, K. Pritchard, 2010, Cancer treatment reviews.

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients

P. Kuppen, J. Dekker, P. J. van den Elsen, 2013, British Journal of Cancer.

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES

P. Lønning, M. Cheang, V. Speirs, 2017, Breast Cancer Research and Treatment.

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

H. Friess, P. Kuppen, T. Schuster, 2011, British Journal of Cancer.

Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.

P. Lønning, M. Cheang, V. Speirs, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial.

H. Putter, C. Seynaeve, J. Nortier, 2018, European journal of cancer.

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

H. Putter, P. Neven, H. Gelderblom, 2015, Breast Cancer Research and Treatment.

Explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients.

W. Otten, S. Jansen, A. Stiggelbout, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial.

H. Putter, J. Nortier, E. Kranenbarg, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

W. E. Mesker, R. Tollenaar, W. Mesker, 2013, Breast Cancer Research and Treatment.

A catalyst for change: the European cancer Patient's Bill of Rights.

J. Bergh, C. la Vecchia, M. Barbacid, 2014, The oncologist.

Prognostic Significance of Metallothionein in Human Gastrointestinal Cancer 1

Cornelis J H van de Velde, Hein W Verspaget, C. V. D. van de Velde, 2002 .

Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer.

Cornelis J H van de Velde, Alexander L Vahrmeijer, John V Frangioni, 2012, Gynecologic oncology.

Natural killer cells infiltrating colorectal cancer and MHC class I expression.

R. Tollenaar, C. V. D. van de Velde, P. Albertsson, 2005, Molecular immunology.

Mechanisms of oncogenesis in colon versus rectal cancer

J. Hermans, E. Kranenbarg, R. Tollenaar, 2001, The Journal of pathology.

Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.

H. Putter, H. Bartelink, L. Collette, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

H. Grabsch, P. Snijders, G. Meijer, 2008, British Journal of Cancer.

The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model

J. A. van der Hage, H. Putter, H. Putter, 2009, Breast Cancer Research and Treatment.

Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification.

H. Putter, A. Vahrmeijer, J. Dekker, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer.

H Putter, H. Putter, J. Nortier, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The role of total mesorectal excision in the management of rectal cancer.

C. V. D. van de Velde, E. Kapiteijn, C. V. D. Velde, 2002, The Surgical clinics of North America.

Self‐reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side‐study

C. Gundy, C. Seynaeve, S. Linn, 2012, Psycho-oncology.

Differences in outcomes of oesophageal and gastric cancer surgery across Europe

V. Coupland, C. V. D. Velde, J. Sandick, 2013, The British journal of surgery.

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

S. H. van der Burg, H. Putter, J. Nortier, 2019, Breast Cancer Research and Treatment.

Reduced rank proportional hazards model for competing risks.

H Putter, H. Putter, J. C. Houwelingen, 2006, Biostatistics.

Long‐term survival with non‐proportional hazards: results from the Dutch Gastric Cancer Trial

H Putter, H. Putter, J. C. Houwelingen, 2005, Statistics in medicine.

Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.

H. Putter, C. V. D. van de Velde, J. V. van Sandick, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis.

R. Tollenaar, R. Turner, D. Morton, 2002, European journal of cancer.

Prognostic significance of dna‐ploidy in a series of 690 primary breast cancer patients

C. V. D. van de Velde, C. Cornelisse, J. Hermans, 1990, International journal of cancer.

Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial

H. Putter, M. Verheij, H. Boot, 2018, The British journal of surgery.

Quality control of lymph node dissection in the Dutch Gastric Cancer Trial

H. Putter, H. Hartgrink, C. V. D. van de Velde, 2015, The British journal of surgery.

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

H. Putter, E. Berns, C. Seynaeve, 2013, Breast Cancer Research and Treatment.

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.

M. J. van de Vijver, C. J. van de Velde, J. V. van Dierendonck, 1998, British Journal of Cancer.